OMX Nordic 40
2.111,40
PKT
-8,25
PKT
-0,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.03.25 | A.P. Moeller - Maersk A-S (B) Sell | Deutsche Bank AG | |
| 27.03.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 25.03.25 | Volvo (B) Underweight | Barclays Capital | |
| 24.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.03.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 18.03.25 | Volvo (B) Buy | Deutsche Bank AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 13.03.25 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 13.03.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 07.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG |